22,625,752 Ordinary Shares of Argenica Therapeutics Limited are subject to a Lock-Up Agreement Ending on 11-JUN-2023.
Details:
As at the date of this Prospectus the Company expects approximately 22,625,750 Shares and 8,300,000 Options to be subject to 24 months escrow, 1,687,500 shares till December 31, 2021, 1,635,000 shares till December 17, 2021 and 1,327,500 shares till October 13, 2021.